No increased risk of taxol toxicity in older patients.
Journal of the American Geriatrics Society.
Times cited: 10
Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy.
Journal of Cancer Research and Clinical Oncology.
Times cited: 6